Target intelligence / Profile preview

UDP glucuronosyltransferase 2 family, polypeptide A3 pseudogene 7 (UGT2A3P7)

Target
UGT2A3P7
Molecular classification
Other, Pseudogene
01

Overview

**UGT2A3P7** is a pseudogene in the human genome belonging to the UDP glucuronosyltransferase (UGT) gene family. It is annotated as "UDP glucuronosyltransferase 2 family, polypeptide A3 pseudogene 7". As a pseudogene, it does not encode a functional protein and does not exhibit enzymatic, transporter, receptor, or other canonical molecular target activity. There is no evidence in current scientific databases that UGT2A3P7 has any biological function, relevance as a drug target, disease association, or pharmacological significance[3][5]. **Context and Supporting Details:** - UGT2A3P7 is specifically identified as a **pseudogene** in authoritative genetic databases, meaning it is a non-functional copy or fragment of a related functional gene[3][5]. - Unlike the related gene UGT2A3, which encodes an active UDP-glucuronosyltransferase enzyme involved in drug metabolism and detoxification[9], UGT2A3P7 does not code for any protein and has no reported function or involvement in glucuronidation, disease pathways, or drug response. - No evidence is present that UGT2A3P7 interacts with drugs, serves as a biomarker, or is involved in disease mechanisms. - Sources describing UGT2A3P7, including commercial reagent databases and genomic information resources, list it as a **pseudogene** only, with no further biological or pharmacological role[3][5]. **Important note:** As a pseudogene, UGT2A3P7 is *not* a molecular target for drugs, is *not* considered a receptor, enzyme, transporter, or any related therapeutic target type, and it is possible that the entity was included based on a misinterpretation of nomenclature (i.e., confusing UGT2A3P7 with its functional paralog UGT2A3). Therefore, "is_incorrect" is set to true, as it is not a valid drug target or functional biological entity.

Other names
UDP glucuronosyltransferase family 2 member A3 pseudogene 7UGT2A3P7

Beyond the preview

Go deeper on UDP glucuronosyltransferase 2 family, polypeptide A3 pseudogene 7 (UGT2A3P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UDP glucuronosyltransferase 2 family, polypeptide A3 pseudogene 7 (UGT2A3P7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call